These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 34017352)
1. Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer. Sun H; Wang Y; Jing HY; Yang XY; Shi XX; Zhang JH; Yu YX; Gao L; Wang XY; Li WH; Yu L Front Genet; 2021; 12():629856. PubMed ID: 34017352 [TBL] [Abstract][Full Text] [Related]
2. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration. Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H Front Genet; 2022; 13():821826. PubMed ID: 35664320 [No Abstract] [Full Text] [Related]
3. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients. Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925 [TBL] [Abstract][Full Text] [Related]
4. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients. Ma J; Yang L; Feng H; Zheng L; Meng H; Li X J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992 [TBL] [Abstract][Full Text] [Related]
5. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma. Wang H; Wang X; Xu L; Lin Y; Zhang J Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942 [TBL] [Abstract][Full Text] [Related]
6. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma. Chen Y; Chen Y; Liu W Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868 [TBL] [Abstract][Full Text] [Related]
7. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma. Zhang T; Shi W; Tian K; Kong Y World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353 [TBL] [Abstract][Full Text] [Related]
8. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study. He T; Yu D; Wang Z; Guo C; Chang Y; Wang D Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891 [TBL] [Abstract][Full Text] [Related]
9. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis. Peng S; Yu J; Wang Y Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma. Li W; Liu J; Zhao H Front Genet; 2021; 12():668871. PubMed ID: 33897772 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer. Huang K; Zeng Y; Xie Y; Huang L; Wu Y Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452 [TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance. Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371 [TBL] [Abstract][Full Text] [Related]
13. Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma. Zeng G; Wang J; Huang Y; Lian Y; Chen D; Wei H; Lin C; Huang Y Onco Targets Ther; 2019; 12():10427-10439. PubMed ID: 31819524 [TBL] [Abstract][Full Text] [Related]
14. CCT6A, a novel prognostic biomarker for Ewing sarcoma. Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265 [TBL] [Abstract][Full Text] [Related]
15. HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A. Yang X; Tong Y; Ye W; Chen L Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35315492 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma. Huang Z; Lai H; Liao J; Cai J; Li B; Meng L; Wang W; Mo X; Qin H Front Oncol; 2021; 11():729230. PubMed ID: 34604068 [TBL] [Abstract][Full Text] [Related]
17. CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status. Zhang H; Zheng T; Qin C; Zhang X; Lin H; Huang X; Liu Q; Chang S; Zhang L; Guo J; Zhang Y; Bian C; Liu H Cancer Gene Ther; 2024 Aug; 31(8):1151-1163. PubMed ID: 38997438 [TBL] [Abstract][Full Text] [Related]
18. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer. Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH Front Genet; 2021; 12():637887. PubMed ID: 33815471 [TBL] [Abstract][Full Text] [Related]
19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
20. Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway. Li B; Lu X; Ma C; Sun S; Shu X; Wang Z; Sun W Neurosci Lett; 2020 Jul; 732():135086. PubMed ID: 32454145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]